BFM
CRL icon

Boothbay Fund Management’s Charles River Laboratories CRL Stock Holding History

Boothbay Fund Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,300
Closed -$2.05M – 2138
2025
Q4 		$2.05M Buy
+10,300
New +$1.87M 0.03% 552
2023
Q4 		– Sell
-2,300
Closed -$451K – 1703
2023
Q3 		$451K Buy
+2,300
New +$472K 0.01% 1075
2023
Q2 		– Sell
-4,346
Closed -$877K – 1896
2023
Q1 		$877K Buy
4,346
+3,346
+335% +$758K 0.02% 1054
2022
Q4 		$218K Buy
+1,000
New +$218K 0.01% 1563
2022
Q3 		– Sell
-7,215
Closed -$1.54M – 2293
2022
Q2 		$1.54M Buy
+7,215
New +$1.76M 0.04% 649
2021
Q3 		– Sell
-572
Closed -$212K – 1936
2021
Q2 		$212K Buy
+572
New +$191K 0.01% 1486
2020
Q2 		– Sell
-6,235
Closed -$787K – 994
2020
Q1 		$787K Sell
6,235
-8,205
-57% -$1.23M 0.07% 358
2019
Q4 		$2.21M Sell
14,440
-2,455
-15% -$340K 0.19% 136
2019
Q3 		$2.24M Buy
+16,895
New +$2.27M 0.21% 120
2016
Q4 		– Sell
-8,086
Closed -$674K – 782
2016
Q3 		$674K Sell
8,086
-576
-7% -$48.3K 0.15% 149
2016
Q2 		$714K Sell
8,662
-2,236
-21% -$184K 0.28% 83
2016
Q1 		$828K Buy
10,898
+4,708
+76% +$349K 0.62% 25
2015
Q4 		$498K Buy
6,190
+287
+5% +$20.7K 0.22% 113
2015
Q3 		$375K Buy
5,903
+2,773
+89% +$199K 0.18% 128
2015
Q2 		$220K Buy
+3,130
New +$232K 0.09% 303

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boothbay Fund Management's CRL Position: Q1 2026 in Review

Boothbay Fund Management sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 10,300 shares — an estimated $2.05M sold.

Boothbay Fund Management first reported a position in CRL in Q2 2015 and held it in 15 quarters. The position peaked at $2.24M in Q3 2019. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Boothbay Fund Management reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 10,300 Charles River Laboratories shares in Q1 2026, an estimated $2.05M.
  • Boothbay Fund Management first reported a position in Charles River Laboratories in Q2 2015 and held it in 15 quarters.
  • Boothbay Fund Management's Charles River Laboratories position peaked at $2.24M in Q3 2019.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.